AHMA
Ambitions Enterprise Management Co. L.L.C
There isn't enough reported data to score AHMA yet.
NIO
NIO Inc.
NIO lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
AHMA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Unavailable |
AHMA's profitability is currently healthy. There isn't enough data to rate its revenue, cash flow and balance sheet.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
AHMA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 29x | $1.16 | -0.8% |
| Current | 29x | $1.17 | — |
| Fair | 35x | $1.42 | +21% |
| Expensive | 96x | $3.82 | +227% |
Historical ranges are pointers, not guarantees.
AHMA's PE is 29x, but its earnings don't support one, so it isn't a reliable read right now.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
AHMA Forward outlook
There aren't enough analyst estimates for AHMA to show an outlook.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect NIO's losses to shrink, with revenue growing.
AHMA Earnings Per Share
AHMA and NIO do not have enough comparable growth data to identify a winner.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
AHMA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $20.2M | +641% |
| Q4 2024 | $2.7M | -25% |
| Q2 2024 | $2.3M | +61% |
| Q4 2023 | $3.6M | +66% |
| Q2 2023 | $1.4M | +60% |
AHMA has the edge over NIO in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 6.4% | +5.8 points |
| Q4 2024 | 9.2% | -2.2 points |
| Q2 2024 | 1.5% | -9.6 points |
| Q4 2023 | 10% | N/A |
| Q2 2023 | 0.6% | N/A |
| Q4 2022 | 11% | N/A |
| Q2 2022 | 11% | N/A |
AHMA's operating margin was 6.4% last quarter, up 5.8 points from the same quarter a year ago.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO's revenue has grown year over year for seven quarters in a row: $4.8B last quarter, up 69% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
AHMA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$1.1M | -646% |
| Q4 2024 | $202.1K | +$317.4K |
| Q2 2024 | $104.3K | +68% |
| Q4 2023 | -$115.2K | -439% |
| Q2 2023 | $61.9K | +$323.5K |
AHMA and NIO do not have enough comparable growth data to identify a winner.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
AHMA Net Leverage
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AHMA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.0 | Neutral |
| Stochastic | 10.6 | Oversold |
AHMA's weekly RSI is 44 (neutral) and its Stochastic is 11 (oversold).
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
AHMA PE vs Consumer Cyclical Sector
| Metric | AHMA | Sector median | Relative |
|---|---|---|---|
| PE | 29x | 18x | 62% above |
| PE % | 19 | 13 | 6 pts above |
AHMA is trading at 29x earnings, a 62% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
AHMA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.21 | 3.3% below |
| 20 week MA | $1.45 | 19% below |
| 50 week MA | $4.31 | 73% below |
NIO has stronger trend alignment. AHMA is above 0 of 3 weekly averages versus NIO above 0 of 5.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
AHMA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $4.46 | $7.38 | +65% |
| 2026 YTD | $7.38 | $1.17 | -84% |
AHMA has finished every year since 2025 higher, and it's down 84% so far in 2026.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO has the edge over AHMA on returns for 2026, with the stronger performance.